Trailhead Biosystems Inc.
PrivateLast Round
Extension
Jan 12, 2026
Total Funding Raised
$18.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Trailhead Biosystems Inc. operates in Healthcare & Life Sciences and is based in Beachwood, Ohio. Its latest recorded funding round was an Extension round in January 2026.
Trailhead Biosystems Inc. is a biotechnology company that develops human cells with defined molecular and functional properties for drug discovery and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trailhead Biosystems Inc. Comparables
Compare Trailhead Biosystems Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iXCells Biotechnologies | 88% | |
| Axol Bioscience | 86% | |
| bit.bio | 84% |
For institutional investors. Book with your work email.
Trailhead Biosystems Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Extension | Jan 12, 2026 | ||||
| VC Round | May 6, 2025 | ||||
| Early Stage VC | Jun 21, 2024 | ||||
| Early Funding | Nov 9, 2023 | ||||
| Series A Extension | Oct 11, 2022 | ||||
Series A | Nov 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trailhead Biosystems Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lorain County Community College Innovation Fund | Seed |
| MAK Capital One | VC Round, Extension, Early Stage VC |
| Innovation Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
TrailBio Endothelial Cells, an iPSC-derived vascular endothelium model, is now commercially available.
- Jan 12, 2026
$20M round led by MAK Capital One.
For institutional investors. Book with your work email.
Trailhead Biosystems Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trailhead Biosystems Inc.'s valuation, stock price, and market status.
Is Trailhead Biosystems Inc. a public or private company?
Trailhead Biosystems Inc. is a private company.
What is the current stock price of Trailhead Biosystems Inc.?
Trailhead Biosystems Inc. is a private company, so its shares have no public market price. Caplight tracks Trailhead Biosystems Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trailhead Biosystems Inc. worth (valuation)?
Valuation information for Trailhead Biosystems Inc. is not publicly available.
Can I buy Trailhead Biosystems Inc. stock?
Trailhead Biosystems Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trailhead Biosystems Inc.'s last funding round?
Trailhead Biosystems Inc.'s most recent funding round was Extension on January 12, 2026.
Who are the main investors in Trailhead Biosystems Inc.?
Key investors in Trailhead Biosystems Inc. include MAK Capital One.
Will Trailhead Biosystems Inc. IPO soon?
No public IPO plans have been announced for Trailhead Biosystems Inc..
How can I track Trailhead Biosystems Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Trailhead Biosystems Inc.'s shares on secondary markets.